Sonoma Pharmaceuticals (SNOA) Enterprise Value (2016 - 2022)
Sonoma Pharmaceuticals (SNOA) has 3 years of Enterprise Value data on record, last reported at -$6.6 million in Q4 2012.
- For Q4 2012, Enterprise Value fell 33.0% year-over-year to -$6.6 million; the TTM value through Dec 2012 reached -$6.6 million, down 33.0%, while the annual FY2012 figure was -$3.4 million, 23.34% up from the prior year.
- Enterprise Value reached -$6.6 million in Q4 2012 per SNOA's latest filing, up from -$8.3 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$3.4 million in Q1 2012 and bottomed at -$8.3 million in Q3 2012.
- Average Enterprise Value over 3 years is -$5.2 million, with a median of -$5.0 million recorded in 2011.
- Peak YoY movement for Enterprise Value: surged 32.51% in 2011, then plummeted 129.43% in 2012.
- A 3-year view of Enterprise Value shows it stood at -$4.7 million in 2010, then fell by 6.16% to -$5.0 million in 2011, then tumbled by 33.0% to -$6.6 million in 2012.
- Per Business Quant database, its latest 3 readings for Enterprise Value were -$6.6 million in Q4 2012, -$8.3 million in Q3 2012, and -$4.4 million in Q2 2012.